Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population

被引:196
作者
Lowe, LC
Guy, M
Mansi, JL
Peckitt, C
Bliss, J
Wilson, RG
Colston, KW
机构
[1] Gen Hosp St Georg, Sch Med, Dept Cellular & Mol Med, London SW7 ORE, England
[2] Inst Canc Res, Sect Clin Trials, Clin Trials & Stat Unit, Surrey, England
[3] St George Hosp, Dept Radiol, London, England
关键词
vitamin D; breast cancer; risk; vitamin D receptor; polymorphism;
D O I
10.1016/j.ejca.2005.01.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Low levels of 25-hydroxy vitamin D (25(OH)D) and polymorphisms in the vitamin D receptor gene (VDR) have been found separately to increase risk of breast cancer. The aim of this study was to determine whether low 25(OH)D levels, alone and in combination with BsmI VDR genotype, increased breast cancer risk in a United Kingdom (UK) Caucasian population. Breast cancer patients (n = 179) and control women (n = 179) were recruited and 25(OH)D levels measured by enzyme-linked immunosorbent assay (ELISA). VDR genotype was determined by polymerase chain reaction (PCR) and restriction enzyme digest. Analysis showed that subjects with 25(OH)D levels < 50 nM and the bb BsmI VDR genotype are 6.82 times more likely to have breast cancer than subjects with levels of 25(OH)D > 50 nM and either the BB or Bb genotype (95 % confidence interval (CI) 2.31-14.7, P < 0.001). This study indicates that low levels of circulating 25(OH)D, both alone and in combination with BsmI VDR genotype, may increase risk of breast cancer in a UK Caucasian population. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1164 / 1169
页数:6
相关论文
共 28 条
[1]   Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population [J].
Bretherton-Watt, D ;
Given-Wilson, R ;
Mansi, JL ;
Thomas, V ;
Carter, N ;
Colston, KW .
BRITISH JOURNAL OF CANCER, 2001, 85 (02) :171-175
[2]  
Chapuy M. C., 1997, Vitamin D., P679
[3]   Vitamin D receptor polymorphisms as markers in prostate cancer [J].
Correa-Cerro, L ;
Berthon, P ;
Häussler, J ;
Bochum, S ;
Drelon, E ;
Mangin, P ;
Fournier, G ;
Paiss, T ;
Cussenot, O ;
Vogel, W .
HUMAN GENETICS, 1999, 105 (03) :281-287
[4]   25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis [J].
Cross, HS ;
Bareis, P ;
Hofer, H ;
Bischof, MG ;
Bajna, E ;
Kriwanek, S ;
Bonner, E ;
Peterlik, M .
STEROIDS, 2001, 66 (3-5) :287-292
[5]   No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer [J].
Dunning, AM ;
McBride, S ;
Gregory, J ;
Durocher, F ;
Foster, NA ;
Healey, CS ;
Smith, N ;
Pharoah, PDP ;
Luben, RN ;
Easton, DF ;
Ponder, BAJ .
CARCINOGENESIS, 1999, 20 (11) :2131-2135
[6]   Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study [J].
Freedman, DM ;
Dosemeci, M ;
McGlynn, K .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 59 (04) :257-262
[7]  
Friedrich M, 2003, RECENT RES CANCER, V164, P239
[8]   SERUM 25-HYDROXYVITAMIN-D AND COLON CANCER - 8-YEAR PROSPECTIVE-STUDY [J].
GARLAND, CF ;
COMSTOCK, GW ;
GARLAND, FC ;
HELSING, KJ ;
SHAW, EK ;
GORHAM, ED .
LANCET, 1989, 2 (8673) :1176-1178
[9]   GEOGRAPHIC-VARIATION IN BREAST-CANCER MORTALITY IN THE UNITED-STATES - A HYPOTHESIS INVOLVING EXPOSURE TO SOLAR-RADIATION [J].
GARLAND, FC ;
GARLAND, CF ;
GORHAM, ED ;
YOUNG, JF .
PREVENTIVE MEDICINE, 1990, 19 (06) :614-622
[10]   Vitamin D receptor gene polymorphisms and breast cancer risk [J].
Guy, M ;
Lowe, LC ;
Bretherton-Watt, D ;
Mansi, JL ;
Peckitt, C ;
Bliss, J ;
Wilson, RG ;
Thomas, V ;
Colston, KW .
CLINICAL CANCER RESEARCH, 2004, 10 (16) :5472-5481